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Summary 
We have examined the role of endogenously produced interleukin (IL) 4 and IL-10 in the regula- 
tion of inflammatory and immune reactions in the skin. In these experiments, irritant  and con- 
tact hypersensitivity (CH) responses were elicited in mice with targeted disruptions of the IL-4 
(IL-4T) or IL-10 (IL-10T) gene. Our study showed that IL-4T and wild-type (wt) mice exhibited 
equivalent responses to the irritant croton oil. In contrast, the response of IL-10T mice challenged 
with croton oil was abnormally increased.  When IL-10T mice were exposed to a higher dose 
of irritant,  irreversible tissue damage occurred. By comparison, any treatment of wt mice with 
croton oil resulted in far less tissue damage and resolution of inflammation.  Neutralizing anti- 
body studies demonstrated that the necrosis ,hat occurred in Ibl0T mice was due to the over- 
production of tumor necrosis factor. The anti-tumor  necrosis factor antibody treatment of IL- 
10T mice did not significantly reduce the edema or the influx of inflammatory cells, suggesting 
that these changes were due to the uncontrolled production of other proinflammatory cytokines. 
T  cell-dependent immune responses were also evaluated using the contact sensitizer oxazolone. 
The response of IL-4T  mice did not  differ from wt mice.  In contrast,  ILol0T mice mounted 
an exaggerated CH response, increased in both magnitude  and duration as compared with wt 
mice. Based on these studies, we have concluded that II,-10, but not IL-4, is a natural suppressant 
of irritant  responses and of CH,  and it limits  immunopathologic  damage in the  skin. 
I 
L-4  and  IL-10 were  first  identified  as  products  of Th2 
clones (1, 2) and are part of the unique cytokine pattern 
that distinguishes Th2 cells from other types of T cells. Th2 
cells are believed to provide major support for the develop- 
ment of humoral immunity. This is due, in part, to the strong 
B cell-stimulating activities of IL-4 and IL-10 (3-6). Numerous 
studies have shown that  IL-4 and IL-10 also possess potent 
immunosuppressive activity. IL-4 and IL-10 can inhibit  the 
synthesis of proinflammatory cytokines by activated macro- 
phages (7-12). Furthermore, IL-4 and IL-10 can inhibit, directly 
or indirectly,  the synthesis of cytokines by Thl clones (12-17). 
Thl cells, in contrast to Th2 cells, produce IFN-~/and TNF-/~ 
and thus have been associated with  the generation  of cell- 
mediated immunity and delayed-type hypersensitivity reac- 
tions (18). Based on the suppressive actions ascribed to IL-4 
and IL-10 in various in vitro assays, it has been predicted that 
IL-4 and IL-10 may negatively regulate inflammatory and cell- 
mediated responses in vivo. 
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Several investigations have focused on the potential of Ib4 
and II:10 to influence immunological reactions in the skin. 
The possibility that ILo4 and IL-10 are normally involved in 
modifying skin reactions seemed likely, since it was found 
that these proteins can be made by certain cell types that re- 
side in the skin. Recent studies have indicated that, in addi- 
tion to Th2 cells,  II,-4 can also be produced by connective 
tissue mast cells (19), which are found in large numbers in 
the skin (20). Production of IL-4 has been documented during 
the sensitization phase of contact hypersensitivity (CH)  1 (21, 
22).  Moreover, IL-4 messenger RNA (mRNA)  expression 
has been associated with the initiation of acute skin inflam- 
mation in patients with atopic dermatitis (23). IL-10 is pro- 
duced in skin by keratinocytes (24-26) and macrophages (10). 
IL-10 mRNA and protein have been detected in intact skin, 
1 Abbreviations used in this paper: CH, contact hypersensitivity; H & E, he- 
matoxylin and eosin; Ib4T, IL-4 gene with targeted disruption; IL-10T, 
Ibl0 gene with targeted disruption; Ibl0T, Ibl0 gene with targeted dis- 
ruption; mRNA, messenger RNA; TNCB, trinitrochlorobenzene; wt, 
wild type. 
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chlorobenzene (TNCB) (24,  26) and UV irradiation (27). 
In a model of CH, it was found that IL-10 can regulate 
both the sensitization and elicitation stages. Injection of mice 
with IL-10 shortly before sensitization with TNCB induced 
anergy (28),  and administration of IL-10 before rechallenge 
diminished the recall response (26, 29). In contrast, the infu- 
sion of mice with IL-4 failed to inhibit the sensitization step 
(30).  Nevertheless,  IL-4 was able to reduce the magnitude 
of the recall response.  These results provided evidence that 
exogenous IL-4 and IL-10 may be administered to suppress 
CH reactions.  To determine whether IL-4 and IL-10 normally 
function as regulators of CH, neutralizing antibodies were 
given to ablate the activities of endogenously produced pro- 
teins.  In mice treated with anti-IL-10 antibodies, the dura- 
tion of the CH response was prolonged (26). In mice treated 
with anti-IL-4 antibodies, there was no effect on the induc- 
tion of CH (21, 30),  whereas the effect on the magnitude 
of the response upon rechallenge was variable  (21, 30). 
We have evaluated the importance of IL-4 and IL-10 in the 
regulation of  inflammatory  and immune reactions in skin using 
mice deficient in the production of IL-4 or IL-10. These mu- 
tant mice were generated by targeted disruptions of the IL-4 
(IL-4T; 31) or IL-10 (IL-10T; 32) gene. Gene-targeted animals 
have proven to be valuable models for delineating the activi- 
ties of various cytokines in complex immunologic responses. 
Our study has focused on the role of endogenously produced 
IL-4 and IL-10 to modify two types of skin responses,  the 
irritant response and CH. 
Materials  and Methods 
Animals.  ID10T  mice generated on a C57B1/6/129 (B6/129) 
background (32) and wild-type (wt) littermate controls were de- 
rived by cesarean section at Simonsen Laboratory (Gilroy, CA) and 
maintained in our animal facility  at DNAX Research Institute (Palo 
Alto, CA). Healthy 5-6-wbold IL-10T mice were used for this 
study. IL-4T  mice (31) bred onto the 129J or C57B1/6J background 
were kindly provided by Dr. R. Coffman (DNAX Research Insti- 
tute), wt 129J and C57B1/6J mice were obtained from The Jackson 
Laboratory (Bar Harbor, ME). 
Reagents and Antibodies.  Oxazolone  (ethoxymethylene-2  phenyl 
oxazolone) and croton oil were obtained from Sigma Chemical Co. 
(St. Louis, MO). Oxazolone was resuspended  in 100% EtOH, and 
croton oil was diluted in acetone. Purified rat anti-mouse TNF 
(XT22) and an isotype-matched  control mAb, anti-~-galactosidase 
(GL-117), were kindly provided  by Dr. J. Abrams (DNAX Research 
Institute).  The  anti-TNF  antibody  XT22  was  elicited against 
TNP-ce, but it neutralizes both TNF-cr and TNF-B (Abrams, J., 
personal communication). 
Experimental Protocols.  The irritant  response was induced by 
applying 10/~1 of 1% (vol/vol) croton oil (low dose) or undiluted 
croton oil (high dose) to the dorsal and ventral aspects of the right 
ear. The reaction was evaluated by measuring the increase in ear 
thickness with time. To induce a chronic skin lesion, undiluted 
croton oil (50 #1) was applied to a 1-cm  z shaved area on the back 
of wt or IL-10T mice. The resulting inflammatory response was 
monitored by measurement of ulcer formation as well as by micro- 
scopic examination. 
CH was elicited by painting the shaved abdomens of mice with 
150/zl of a 3% solution of oxazolone. After 6 d,  10 #1 of 1% 
oxazolone was applied to the dorsal and ventral sides of the right 
ear. The reaction was evaluated by measuring ear thickness with 
an engineer's caliper (Mitutoyo/MTI, Paramus, NJ). The amount 
of swelling at 24, 48, 72, and 96 h after challenge  was determined 
by measuring the difference in ear swelling in challenged (right) 
and unchallenged (left) ears. 
Histologic Analysis.  Tissues  from mutant and normal mice were 
fixed in 10% neutral buffered formalin, routinely processed, sec- 
tioned at 6 #m, and stained with hematoxylin and eosin (H & E). 
Tissue sections were graded semiquantitatively  by the same pathol- 
ogist (M. W. Leach) as 0 (no change) to 4 (most severe). 
Treatment with Anti-TNF Antibodies.  Mice  were injected in- 
traperitoneally  with 2 mg of anti-TNF mAb or anti-~-galactosidase 
mAb 4 h before the application of croton oil. The same lot and 
amount of the anti-TNF mAb used here has been shown to ablate 
the effects  of  endogenously  produced TNF in several  in vivo models 
(17, 33, 34). 
StatisticalAnalysis.  Significant  differences  between experimental 
groups were evaluated  by the nonparametric  Mann Whitney U test. 
Results 
Irritant Responses of lL,4T and ILIOT Mice  Data presented 
in Fig.  1 show the irritant responses of IL-4T and wt mice 
after challenge with the irritant, croton oil. After exposure 
to 1% croton oil, maximal swelling was detected at 24 h, 
with a significant decrease by 48 h  (Fig.  1 A). The IL-4T 
mice did not differ from wt in their response to the irritant. 
When the mice were challenged with a higher dose of irri- 
tant, increased swelling was observed at 24 h and maintained 
at 48 h (Fig.  1 B). As with the low-dose treatment, there 
was no difference between Ib4T and wt mice. 
The data presented in Fig. 2 show that the irritant responses 
of Ibl0T and wt mice were markedly different. After ex- 
posure to 1% croton oil, the swelling in Ibl0T mice was 
twice that of wt mice (Fig.  2 A). Furthermore, compared 
with the 24-h measurement, the swelling observed  in the 
IL-10T ears was only slightly decreased after 48 h, whereas 
the swelling at 48 h in wt mice was diminished by nearly 
50%. To further evaluate the altered irritant responses in IL- 
10T mice, we used croton oil at a higher concentration. We 
found that the swelling in IL-10T mice did not differ signi- 
ficantly from wt mice at 24 h (Fig. 2 B). At 48 h the reaction 
in the wt ears remained high, whereas, unexpectedly, the ears 
of Ibl0T mice showed no evidence of sweUing (Fig.  2 B). 
WT and Ibl0T ears were examined microscopically (Fig. 
3). After challenge with 1% croton oil, wt ears (Fig. 3 C) 
had a predominantly dermal infiltrate of granulocytes and 
mononuclear ceUs, mild edema, and mild hemorrhage. Oc- 
casional intraepidermal pustules were also present. The IL- 
10T ears elicited with 1% croton oil (Fig.  3 D) showed a 
more extensive inflammatory  cell infiltrate in the dermis, with 
more edema, moderate hemorrhage, and focal areas of epi- 
thelial necrosis.  There was also an increase in the frequency 
and size of intraepidermal pustules. 
Exposure to high-dose croton oil-induced lesions  in wt 
ears was consistent with a severe inflammatory  response. The 
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Figure  1.  Irritant responses of IL-4T mice. The increases in ear thick- 
ness of IL-4T and wt mice on a  129J background (129J) were measured 
24 and 48 h after application of 1% croton oil (low dose; A) and undiluted 
croton oil (high dose; B).  Data presented are the mean values  _+  SD of 
six mice per group and are representative of two independent experiments. 
Differences between  the two  groups  were  not  significant, P  >0.05. 
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Figure  2.  Irritant responses of IL-10T mice. The increases in ear thick- 
ness of ID10T and wt mice on a B6/129 background were measured 24 
and 48 h  after application of 1% croton oil (low dose; A) and undiluted 
croton oil (high dose; B).  Data presented are the mean values  _+  SD of 
six mice per group and are representative of three independent experiments. 
An arrow indicates that no increase in ear thickness was detected. *P <0.01 
compared with values obtained with wt mice at the same time point;  t 
P  <0.01  compared  with  wt  at  24 h. 
Figure  3.  Histologic analysis of the irritant response. Photomicrographs of mouse ears after croton oil treatment (H &  E;  x180).  (A) wt ear,  un- 
challenged.  (B) Ibl0T ear,  unchallenged.  (C)  wt  ear challenged with  1% croton oil,  24 h.  Ear thickening is due to edema and moderate numbers 
of inflammatory cells.  There is slight epidermal thickening (open star) secondary to cdlular proliferation (acanthosis).  (D) Ibl0T ear challenged with 
1% croton oil, 24 h. As in the wt, ear thickening is due to edema and infiltration of inflammatory cells.  The cartilage is not seen in this field because 
of extensive edema. Epidermal thickening (open star) is secondary to edema rather than cellular proliferation. A large intraepidermal pustule is present 
(upper  left,  arrow).  (E)  wt  ear challenged with  100%  croton oil,  48  h.  This is similar to C,  but  there is more edema,  and marked acanthosis (open 
star) is present. (F) IL-10T ear challenged with undiluted croton oil, 48 h. The ear is completely necrotic. (G) Ear of wt mouse treated with anti-TNF 
antibody and challenged with  100%  croton oil, 48 h.  (H) Ear of IL-10T mouse treated with  anti-TNF  antibody and challenged with  100%  croton 
oil,  48  h.  Edema and inflammatory cell infiltrate are present,  but  there is no necrosis.  An open star indicates epidermis;  a dosed  star,  dermis;  and 
a  triangle,  cartilage. 
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tive field at 48 h is shown in Fig. 3 E). Similar lesions were 
also observed in IL-10T ears 24 h after exposure to high-dose 
croton oil. In addition, blood vessels containing fibrin thrombi 
and small areas of hemorrhage were observed in IL-10T ears. 
By 48 h  the ears of IL-10T mice had extensive  necrosis  of 
most of the tissue (Fig. 3 F).  The tissue death accounted 
for the absence of measurable swelling at the 48-h time point 
shown in Fig.  2/i 
Effects of  Anti-TNF Antibodies on the Irritant Response to Croton 
Oil.  Anti-TNF antibodies were administered to IL-10T and 
wt mice 4 h before challenge with croton oil. Using the low- 
dose protocol, it was found that treating IL-10T mice with 
antibodies did not significantly reduce their ear swelling at 
24 h, although a small reduction was seen at 48 h  (Fig.  4 
A). Antibody treatment of wt mice reduced their modest 
ear  swelling by >50%  at 24  h  (Fig.  4 A). 
Using the high-dose protocol, anti-TNF antibodies had 
no effect on the large response elicited in wt and IL-10T mice 
at 24 h, and significant ear swelling was observed (Fig. 4 B). 
Similarly,  the anti-TNF treatment had no effect on the sus- 
tained response of wt mice at 48 h. However, anti-TNF was 
found to preserve  tissue viability in IL-10T mice, resulting 
in the significant ear swelling detected at 48 h  (Fig.  4 B). 
Microscopic examination confirmed the beneficial effects 
of the anti-TNF treatment. The necrosis observed in the IL- 
10T mice was dramatically reduced (compare Fig. 3, F and 
H), demonstrating the contribution of TNF to the excessive 
tissue damage. The focal necrosis observed in wt mice at the 
high dose was also eliminated. However, the anti-TNF anti- 
body treatment did not prevent edema or the accumulation 
of large numbers of inflammatory cells (Fig.  3,  G  and H). 
Histopathology of Chronic Lesions Elicited with an Irritant.  Be- 
cause the mouse ear is very thin, severe damage elicited with 
high-dose croton oil resulted in complete necrosis of the Ib 
10T  ears. This  event  precluded  additional  studies  of the 
pathology associated with chronic inflammation and tissue 
repair.  Therefore, a high dose of croton oil was applied to 
the backs of IL-10T and wt mice, as the same (or greater) 
depth of necrosis in this location would cause ulceration yet 
leave an underlying bed of tissue from which repair could 
take place. Several days after application of croton oil, ulcera- 
tions developed  in both the wt and IL-10T mice, but they 
were larger in the IL-10T animals.  Microscopic examination 
revealed moderate inflammation, ulceration, and fibrosis in 
the skin of the wt anirr:als (Fig. 5 A). In contrast, the backs 
of the IL-10T mice treated with croton oil showed severe 
inflammation, necrosis, fibrosis, and serocellular crusting (Fig. 
5 B). While the inflammation in the wt mice involved only 
the skin,  IL-10T mice showed extensive inflammation ex- 
tending through the body wall involving muscle and the lining 
of the body cavity (parietal  peritoneum). As a result, adhe- 
sions  developed  between the peritoneum and the liver. 
Contact  Hypersensitivity  Responses  of IL-4T  and  IL.IOT 
Mice.  To further evaluate the role of IL-4 and IL-10 in skin 
responses,  we examined the T  cell-dependent CH response 
in wt, IL-4T, and IL-10T mice.  Data presented in Fig. 6 A 
Figure 4.  Effects  of anti-TNF antibody  treatment on the irritant re- 
sponse. AntbTNF  or isotype  control  mAbs were given  to IL-10T  and wt 
mice 4 h before application of 1% croton oil (A), or undiluted  croton 
oil (B). Data presented  are mean  values _+ SD of six mice  per group mea- 
sured at 24 and 48 h after  application  of the irritant and are representative 
of two independent  experiments. An arrow indicates  that no increase in 
ear thickness  was detected. *P <0.01 compared  with values  obtained  with 
wt mice treated with isotype control antibody. 
show the CH responses of IL-4T mice and wt mice after sen- 
sitization and rechallenge with oxazolone, wt and IL-4T mice 
on a C57B1/6 background gave identical responses to the sen- 
sitizing agent. Similarly, no difference was seen between wt 
and IL-4T mice on a 129/J background, although the mag- 
nitude of the CH response  was greater than that observed 
with C57B1/6J mice, demonstrating the contribution of strain 
differences  to the CH response. 
In the same type of experiment, the ear swelling of Ibl0T 
(B6/129)  mice  was  found to be  greater  than  that  of wt 
(B6/129)  mice at 24  h, when the response peaked (Fig.  6 
B).  In addition, the response was greatly prolonged in IL- 
10T  mice,  as swelling was maintained 4 d  after challenge. 
Microscopic examination revealed an exaggerated inflamma- 
tory response in the IL-10T mice.  As expected, the applica- 
tion of oxazolone to the ears of sensitized wt mice resulted 
in significant edema and in the accumulation of mononuclear 
cells and neutrophils (Fig. 7 A). In the wt mice, intraepidermal 
pustules containing neutrophils and fewer eosinophils were 
noted on the ear surface. The underlying edematous dermis 
and skeletal muscle tissue contained scattered mixed inflam- 
matory cells, including granulocytes and mononuclear cells. 
Changes in the ear of IL-10T elicited mice were qualitatively 
similar but were significantly more severe than those seen 
in the wt elicited mice (Fig.  7 B). Epidermal pustules were 
103  Berg et al. Figure  5.  Histologic  analysis  of chronic lesions elicited  with croton oil. Photomicrographs  of lesions 14 d after treatment of skin with undiluted 
croton oil (H & E;  x68). (A) wt lesion showing  extensive  granulation tissue in the dermis. The overlying  epidermis still has ulceration  (open star), 
but epidermal cells are present at the edge of the ulcer (arrow). (B) IDIOT lesion, field  comparable to A. Granulation  tissue is present only  in the 
very deep dermis (arrows); all the material above the arrows is necrotic. No reepithelialization  is present. 
larger and more frequent, and in many areas they became 
confluent,  sometimes  forming  seroceUular  crusts  on  the 
surface. 
Discussion 
The skin is a site of significant immunologic activity be- 
cause of its constant exposure to physical  trauma, chemical 
irritants, and infectious organisms. A complex set of  immune 
reactions has evolved to provide an appropriate defense under 
a variety of circumstances. An integral part of the immune 
response is a mechanism for controlling inflammatory and 
immune reactions to prevent immunopathologic damage. We 
have investigated the roles of IL-4 and IL-10 as regulators of 
immune responses  in skin by studying the outcome of irri- 
tant responses  and CH in IL-4T  and IL-10T mice. 
The first type of skin reaction examined was the irritant 
response induced by croton oil. This response is T cell inde- 
pendent and does not require prior sensitization. Instead, the 
mechanism of development depends upon the ability of a 
chemical compound to induce the production of inflamma- 
tory mediators by cells in the skin (35), particularly keratino- 
cytes (36) and Langerhans cells (37). The role of IL-10 in the 
regulation of the irritant response has not been extensively 
studied. In a previous study, mRNA for ILIO  was not in- 
duced after application of the irritant, sodium lauryl sulfate 
(24). In another study, IL-10 administration did not alter the 
irritant response (29). These reports suggested that the irri- 
tant response was not regulated by IL-10, in contrast to CH. 
However, we have found that the application of croton oil 
to the skin of IL-10T mice produced intense inflammation 
characterized by edema and leukocyte infiltration. This re- 
sponse was much greater in magnitude and more persistent 
than that observed in similarly treated wt mice, demonstrating 
a clear role for IL-10 in the regulation of an irritant response. 
The role of IL-4 in the irritant response  has not been inves- 
tigated. Our studies showed no alteration in the irritant re- 
sponse in IL-4T animals.  These data suggest that IL-10, but 
not IL-4, functions as a negative regulator of the irritant re- 
sponse  in skin. 
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Figure  6.  CH responses of IL-4T and IL-10T mice. The increases in 
ear thickness  of sensitized interleukin-deficient  and wt mice were mea- 
sured daily after challenge with oxazolone. Data presented are the mean 
values  +_SD of six mice per data point.  (/1) Differences between IL-4T 
and wt mice (129J) were not significant, P ;>0.05. Data are representative 
of two independent  experiments. Differences between IL-4T and wt mice 
(C57B1/6J) were not significant, P ;>0.05. -CF-, wt (129J); -I-,  ID4T 
(129J); -O-- wt (C57B1/6);  --0- IL-4T (C57B1/6).  (B) Differences be- 
tween IL-10T and wt mice (B6/129) were significant,  *P <0.01. Data are 
representative  of three  independent  experiments.  -C~,  wt  (B6/129); 
-I-,  IL-10T  (B6/129). 
The importance of IL-10's ability to dampen the irritant 
response was most dearly illustrated by using a higher dose 
of the irritant. When the ears of I1"10T mice were challenged 
with a high dose of croton oil, we found extensive tissue 
necrosis but little evidence of inflammatory  cells, suggesting 
that tissue death occurred rapidly and was secondary to ex- 
cessive inflammatory cytokine production by the resident skin 
cells rather than by infiltrating leukocytes. In the case of wt 
mice challenged with the higher dose, the inflammatory re- 
sponse was  amplified overall with only scattered areas of 
hemorrhage and epithelial necrosis. These differing outcomes 
demonstrated that I1"10 is essential for modifying  inflamma- 
tory reactions to prevent unnecessary tissue damage. 
TNF  appears to  be  the  major  mediator  of cutaneous 
pathology associated with reactions to contact sensitizers and 
irritants  (38). Previous studies have shown that intradermal 
injections of TNF-oe into normal mice produced edema, leu- 
kocyte sequestration  along the venules, and focal areas of 
necrosis and hemorrhage (38, 39). Conversely, anti-TNF an- 
tibody treatment of unsensitized and TNCB-sensitized mice 
reduced all of these components upon TNCB challenge (38). 
We found that anti-TNF antibody treatment of I1-10T mice 
challenged with a high dose of croton oil prevented hemor- 
rhage and tissue necrosis and allowed for the development 
of an inflammatory response. These results clearly implicate 
excessive TNF production in the I1"10T mice as the cause 
of necrosis and suggest  that  the overproduction of other 
inflammatory  mediators (e.g., Ibl, I1"6, chemokines, prosta- 
glandins, leukotrienes,  etc.) was the major cause of edema 
and cell recruitment. 
The consequences  of an uncontrolled inflammatory response 
became more apparent when we studied the lesions on the 
backs of wt and I1"10T mice painted with croton oil. The 
inflammation elicited in wt mice was limited to the skin, 
and reepithelialization was evident by 2 wk after exposure. 
The inflammatory response in I1"10T mice was much greater, 
involving not only the skin but the entire body wall. Exten- 
sive tissue necrosis occurred in I1"10T mice, and there was 
minimal evidence of healing.  The delay in resolution may 
have been secondary to differences in the size of the lesions 
elicited; however, inhibition of healing cannot be ruled out. 
Previous studies have demonstrated that TNF has an inhibi- 
tory effect on wound healing (40, 41), and hence it is pos- 
sible that excessive production of TNF in IL-10T mice may 
have impaired their ability to heal the wound. 
The second type of skin reaction studied was CH, which 
is a T cell-dependent immune response that requires prior 
sensitization. CH is a complex immunologic phenomenon, 
and there are multiple ways in which it may be regulated 
by IL-10. Results of  mRNA studies suggest that proinflamma- 
tory cytokines and chemokines are produced early during the 
initiation phase of CH (36). Keratinocytes and macrophages 
are major sources of these factors, as well as of I1"10, which 
is known to down-regulate the production of proinflamma- 
tory cytokines (10, 11, 24, 25). Based on evidence provided 
by in vitro (10, 11) as well as in vivo studies (28), it seems 
likely that the absence  of 11"10 would permit the uncontrolled, 
local production of proinflammatory cytokines, leading to 
an increased  response. Other potential sources of  proinflamma- 
tory cytokines,  as well as II.-10, are activated CD4+  and 
CD8 + T cells (15, 42), which are key participants  in CH 
(43-45). Several studies have documented that I1"10 inhibits 
the APC function of macrophages (12-14) and Langerhans 
cells (46) that is required for the activation of cytokine produc- 
tion by CD4 + T cells. Furthermore, II-10 has the potential 
to ablate CH in vivo by inducing anergy in allergen-reactive 
T cells (27, 28). Therefore, I1-10 may modulate the CH re- 
sponse by inhibiting T  cell-APC interactions. 
Our data show that I1-10T mice develop an exaggerated 
CH response after sensitization and subsequent challenge with 
oxazolone. As a result, both the magnitude and duration of 
the response were increased  beyond those observed in wt mice. 
Histologic analysis revealed that the responses of I1-10T and 
wt mice differed quantitatively but not qualitatively. Thus, 
the increased reaction in the ears of I1-10T mice could be 
accounted for by the presence of a larger cellular infiltrate 
and increased edema. In mice depleted of 11-10 by neutralizing 
antibodies (26), the duration, but not the magnitude, of the 
CH response was increased. The discrepancy between the 
results obtained with I1"10T mice and with the antibody- 
treated mice may reflect that, in our study, I1-10 was absent 
during both the sensitization and elicitation phases, whereas 
I1-10 was absent during only the elicitation phase in the an- 
105  Berg et al. Figure  7.  Histologic analysis of the CH response. (A) wt ear 24 h after challenge with oxazolone. Ear thickening is due to edema and mild infiltration 
of inflammatory cells (H & E;  x 34). (B) IL-10T  ear 24 h after challenge with oxazolone. The IL-10T  ear is thicker than the wt ear because of increased 
edema and inflammatory cell infiltration. Of note are the numerous intraepidermal pustules (H & E;  x34).  (C) Higher magnification of wt ear chal- 
lenged with oxazolone (H & E;  x180). Intraepidermal pustules are small (arrow). (D) Higher magnification of IL-10T  ear challenged with oxazolone 
(H & E;  x 180). Intraepidermal pustules (arrow) are larger and more numerous, and they obscure the dermal-epidermal junction.  An open star indicates 
epidermis; a closed star, dermis; and a triangle, cartilage. 
tibody study. The lack of regulation by IL-10 ofT cell-APC 
interactions  during  the  sensitization  phase  may  have con- 
tributed to the increased magnitude of the CH response seen 
in  the  IL-10T mice. 
Surprisingly,  our studies with  IL-4T mice failed to dem- 
onstrate  any alteration  in their CH  response due to the ab- 
sence of ILo4. This was unexpected, considering the previous 
report of IL-4 production in vivo in response to contact sen- 
sitizers,  including  oxazolone  (21,  22).  Studies  using  neu- 
tralizing antibodies to IL-4 have found variable effects on the 
elicitation phase of CH (21, 30),  and in our hands anti-IL-4 
treatment  of wt mice at elicitation  did not  result  in  an in- 
creased  CH  response  (data  not  shown).  When  IL-4T mice 
on either the 129/J or C57B1/6J background were evaluated, 
no  differences  from wt  were detected  in  the  CH  response. 
Our study, using two strains of mice deficient in the produc- 
tion of IL-4, has led us to conclude that IL-4 does not regu- 
late  the  magnitude  or  duration  of the  CH  response. 
In summary, our data demonstrate that endogenously pro- 
duced  I1,-10,  but  not  IL-4, is an essential regulator  of both 
irritant and CH responses in the skin. There is similarity be- 
tween these results and our previous finding that the absence 
of IL-10 resulted in the development of an exaggerated inflam- 
matory response in the gastrointestinal  tract (32).  Both the 
skin and the gastrointestinal tract are exposed to large numbers 
of potential antigens and irritants. The immune response must 
be  carefully balanced  so  that  a  proper  defense  is  mounted 
without causing excessive immunopathologic  damage. Our 
studies indicate that the role of IL-10, i.e., to prevent prolonged 
and exaggerated immune/inflammatory responses to antigens 
and irritants,  is similar in both the skin and the gastrointes- 
tinal  tract. 
106  Contact  Hypersensitivity and Irritant  Responses in IL-4T and IL-10T Mice The authors gratefully acknowledge the expert technical assistance of Ms. B. D. Hartman and the staff 
of the Histology Laboratory at the Schering-Plough Research Institute, especially Mr. J. Syed. We also 
thank Ms.  Romy Brock for assistance  in preparation of the manuscript. 
Address correspondence to Dr. Donna Rennick, DNAX  Research Institute, 901 California Ave., Palo 
Alto, CA 94304. 
Received for publication 22 November  1994 and in revised form 24 February 1995. 
References 
1.  Mosmann, T.R., H. Cherwinski, M.W. Bond, M.A. Giedlin, 
and R.L. Coffman. 1986. Two types of murine helper T cell 
clones.  I. Definition according to profiles of lymphokine ac- 
tivities and secreted  proteins. J. Immunol. 136:2348-2357. 
2.  Fiorentino, D.F., M.W. Bond, and T.R. Mosmann. 1989. Two 
types of mouse T helper cell. IV. Th2 clones secrete a factor 
that inhibits cytokine production by Thl clones.J. Exp. Med. 
170:2081-2095. 
3.  Paul, W.E., andJ. Ohara. 1987. B-cell stimulatory factor-1/In- 
terleukin 4. Annu. Rev. Immunol. 5:429-459. 
4.  Go, N.F., B.E. Castle, R. Barrett, R.  Kastelein,  W. Dang, 
T.R. Mosmann, K.W. Moore, and M. Howard. 1990. Inter- 
leukin 10, a novel B cell stimulatory factor: unresponsiveness 
of X chromosome-linked immunodeficiency B cells. 1990. J. 
Extz Med. 172:1625-1631. 
5.  Rousset, F., E. Garcia,  T. Defiance, C. Peronne, D.-H. Hsu, 
R. Kastelein,  K.W. Moore, and J. Banchereau. 1992. IL-10 is 
a potent growth and differentiation factor for activated human 
B lymphocytes. Proc. Natl. Acad. Sci. USA.  89:1890-1893. 
6.  Defiance, T., B. Vanbervliet, F. Bri~re, I. Durand, F. Rousset, 
and J.  Banchereau.  1992.  Interleukin  10 and  transforming 
growth factor fl cooperate to induce anti-CD40-activated naive 
human B cells to secrete  immunoglobulin A.J.  Exp. Ailed. 
175:671-682. 
7.  Essner, R., K. Rhoades, W.H. McBride, D.L. Morton, and 
J.S. Economou. 1989. IL-4 down-regulates IL-1 and TNF gene 
expression in human monocytes.J. Immunol. 142:3857-3861. 
8.  Brantschen, S., J.F. Gauchat, A.L. DeWeck, and B.M. Stadler. 
1989. Regulatory effect of recombinant interleukin (IL)-3 and 
1I,-4 on cytokine gene expression of bone marrow and periph- 
eral blood mononuclear cells. Eur.  J. Immunot. 19:2017-2023. 
9.  Hart, P.H., G.F. Bitti, D.R. Burgess, G.A. Whitty, D.S. Pic- 
coli,  and J.A.  Hamilton.  1988.  Potential antiinflammatory 
effects of interleukin 4: suppression of human monocyte tumor 
necrosis  factor c~, interleukin 1, and prostaglandin E2. Proc. 
Natl. Acad. Sci. USA.  86:3803-3807. 
10.  de Waal Malefyt, R., J. Abrams, B. Bennett, C.G. Figdor, and 
J.E. de Vries. 1991. Interleukin 10 (Ibl0) inhibits cytokine syn- 
thesis by human monocytes: an autoregulatory role of IL-10 
produced by monocytes. J. Exp. Med. 174:1209-1220. 
11.  Fiorentino, D.F., A. Zlotnik, T.R. Mosmann, M.H. Howard, 
and A. O'Garra. 1991. IL-10 inhibits cytokine production by 
activated macrophages. J. Immunol. 147:3815-3822. 
12.  Fiorentino, D.F.,  A. Zlotnik, P. Viera,  T.R. Mosmann,  M. 
Howard, D.W.  Moore, and A. O'Garra.  1991. IL-IO acts on 
the antigen-presenting cell to inhibit cytokine production by 
Thl cells. J, Immunol. 146:3444-3451. 
13.  Ding, L., and E.M.  Shevach.  1992.  IL-10 inhibits mitogen- 
induced T  cell proliferation by selectively inhibiting macro- 
phage costimulatory function. J. Immunol. 148:3133-3139. 
107  Berg et al. 
14.  de Waal Malefyt, R., J. Hannen, H. Spits, M.-G. Roncarolo, 
A. te Velde, C. Figdor, K. Johnson, R. Kastelein,  H. Yssel, 
and J.E. de Vries. 1991. Interleukin 10 (Ibl0) and viral IL-10 
strongly reduce antigen-specific  human T cell proliferation by 
diminishing the antigen-presenting capacity of monocytes via 
downregulation of class II major histocompatibility complex 
expression. J. Exp. Med. 174:915-924. 
15.  Peleman,  R., J.  Wu,  C.  Fargeas,  and G. Delespesse.  1989. 
Recombinant interleukin 4 suppresses  the production of in- 
terferon y  by human mononuclear cells. J. Exp. Med. 170: 
1751-1756. 
16.  Vercelli, D., H.H. Jabara,  R.P. Lauener, and R.S. Geha. 1990. 
Ib4 inhibits the synthesis of IFN-~ and induces the synthesis 
of IgE  in  human  mixed lymphocyte cultures. J.  Immunol. 
144:570-573. 
17.  Powrie, F., S. Menon, and R.L. Coffman. 1993. Interleukin-4 
and interleukin-10 synergize to inhibit cell-mediated  immu- 
nity in vivo. Eur. J. Immunol. 23:3043-3049. 
18.  Chef, D.J., and T.R. Mosmann.  1987. Two types of murine 
helper T cell clone. II. Delayed-type hypersensitivity is medi- 
ated by Thl clones. J. Immunol. 138:3688-3694. 
19.  Bradding, P., I.H. Feather,  P.H. Howarth, R. Mueller, J.A. 
Roberts, K. Britten, J.P.A. Bews, T.C.  Hunt, Y. Okayama, 
C.H. Heusser, G.R. Bullock, M.K. Church, and S.T. Holgate. 
1992. Interleukin 4 is localized to and released by human mast 
cells, j. Exp. Med. 176:1381-1386. 
20.  Mikhail, G.R., and A. Miller-Milinska.  1964. Mast cell popu- 
lation in human skin. j. Invest. Dermatol. 43:249-254. 
21.  Thomson, J.A., A.B. Troutt, and A. Kelso. 1993. Contact sen- 
sitization to oxazolone: involvement of both interferon-gamma 
and interleukin-4 in oxazolone-specific Ig and T-cell responses. 
Immunology. 78:185-192. 
22.  Mohler, K.M., and L.D. Butler. 1990. Differential production 
of IL-2 and IL-4 mRNA in vivo after primary sensitization. 
J. Immunol. 145:1734-1739. 
23.  Hamid, Q., M. Boguniewicz, and D.Y. Leung. 1994. Differen- 
tial in situ cytokine gene expression  in acute versus chronic 
atopic dermatitis. J.  Clin. Invest. 94:870-876. 
24.  Enk, A.H., and S.I. Katz. 1992. Identification and induction 
of keratinocyte-derived IL-10. J. Immunol. 149:92-95. 
25.  S.E. Ullrich. 1994. Mechanism involved in the systemic sup- 
pression of antigen-presenting cell function by UV irradiation. 
Keratinocyte-derived II,-10 modulates antigen-presenting cell 
function of splenic adherent cells.J. Immunol. 152:3410-3416. 
26.  Ferguson, T.A., D. Philip, and T.S. Griffith. 1994. Regulation 
of contact hypersensitivity by interleukin  10. J. Exp. Med. 
179:1597-1604. 
27.  Rivas, J.M., and S.E. Ullrich. 1992. Systemic suppression  of 
delayed-type hypersensitivity by supernatants from UV-irradi- 
ated keratinocytes. An essential role for keratinocyte-derived IL-10. J. lmmunol.  149:3865-3871. 
28.  Enk, A.H., J. Saloga, D. Becket, M. Mohamadzadeh, and J. 
Knop.  1994. Induction of hapten-specific  tolerance by inter- 
leukin  10 in vivo. f  Exl~  Med.  179:1397-1402. 
29.  Schwarz, A., S. Grabbe, H. Riemann, Y. Aragane, M. Simon, 
S. Menon, S. Andrade, T.A. Luger, A. Zlotnik, and T. Schwarz. 
1994. In vivo effects of interleukin-10 on contact hypersensi- 
tivity and ddayed-type hypersensitivity reactions.J. Invest. Der- 
matol.  103:211-216. 
30.  Gautam, S.C., N.F. Chikkala, and T.A. Hamilton. 1992. Anti- 
inflammatory action of Ib4.  Negative regulation of contact 
sensitivity to trinitrochlorobenzene.f Immunol. 148:1411-1415. 
31.  Kfihn, R., K. Rajewsky, and W. Mfiller. 1991. Generation and 
analysis of interleukin-4 deficient mice.  Science (Wash. DC). 
254:707-710. 
32.  Kfihn, K., J. Lohler, D. Kennick, K. Rajewsky, and W. Mfiller. 
1993. Interleukin-10-deficient mice develop chronic enteroco- 
litis.  Cell. 75:263-274. 
33.  Brocke, S., A. Gaur, C. Piercy, A. Gautam, K. Gijbels, C.G. 
Fathman, and L. Steinman. 1993. Induction of relapsing  pa- 
ralysis in experimental autoimmune encephalomyelitis by bac- 
terial superantigen. Nature (Lond.). 365:642-644. 
34.  Hunter, C.A.,J.S. Abrams, M.H. Beaman, andJ.S. Remington. 
1993. Cytokine mRNA in the central nervous system of SCID 
mice infected with  Toxoplasrna gondii: importance of T-cell- 
independent reguhtion of resistance to 7?. gondii. Infect. Immun. 
61:4038-4044. 
35.  Wilmer, J.L., F.G. Burleson, F. Kayama, J. Kanno, and M.I. 
Luster. 1994. Cytokine induction in human epidermal keratino- 
cytes exposed to contact irritants and its relation to chemical- 
induced inflammation in mouse skin../. Invest. Dermatol. 102: 
915-922. 
36.  Enk, A.H., and S.I. Katz. 1992. Early molecular events in the 
induction phase of contact sensitivity. Proa Natl. Acad. Sci. USA. 
89:1398-1402. 
37.  Enk, A.H., V.L. Angeloni, M.C. Udey, and S.I. Katz. 1993. 
An essential role for Langerhans cell-derived IL-lb in the initi- 
ation of primary immune responses in skin.J. Imrnunol. 150: 
3698-3704. 
38.  piguet, P.F., G.E. Grau, C. Hanser, and P. VassaUi. 1991. Tumor 
necrosis factor is a critical mediator in hapten-induced irritant 
and contact hypersensitivity reactions.J. Ex  F Med.  173:673- 
679. 
39.  Piguet, P.E 1993. TNF and the pathology of the skin.  Res. 
Immunol.  144:320-326. 
40.  Rapala,  K., M. Laato, J. Niinikoski, H. Kujari, O. Soder, A. 
Mauviel, andJ.P. Pujol. 1991. Tumor necrosis factor alpha in- 
hibits wound healing in the rat. Fur. Surg. Res. 23:261-268. 
41.  Salomon, G.D., A. Kasid,  D.T. Cromack, E. Director, T.L. 
Talbot, A. Sank,  and J.A. Norton. 1991. The local effects of 
cachectin/tumor necrosis factor on wound healing. Ann. Surg. 
214:175-180. 
42.  Fong, T.A., and T.K. Mosmann.  1990. Alloreactive murine 
CD8 + T cell clones  secrete the Thl pattern of cytokines, j. 
Immunol.  144:1744-1752. 
43.  Vada, M.A., J.EA.P. Miller, I. McKenzie, S.E. Chism, E-W. 
Shen,  E.A. Boyse, J.R. Gamble, and A.M. Whitelaw.  1976. 
Ly and Ia antigen phenotypes of T cells involved in delayed- 
type hypersensitivity and in suppression.J. Exl~ Med. 144:10-19. 
44.  Sunday, M.E.,  and M.E. Doff. 1981. Hapten-specific  T  cell 
response to 4-hydroxy-3-nitrophenyl acetyl. X. Characteriza- 
tion of distinct T cell subsets mediating cutaneous sensitivity 
responses, j.  Immunol.  127:766-768. 
45.  Gocinskin,  G.L., and K.E.  Tigelaar.  1990. Koles of CD4 + 
and CD8 + T  cells in murine contact sensitivity revealed by 
in vivo monoclonal antibody depletion.J. Immunol.  144:4121- 
4128. 
46.  Enk, A.H., V.L. Angeloni, M.C. Udey, and S.I. Katz. 1993. 
Inhibition of Langerhans cell antigen-presenting function by 
IL-10. A role for IL-10 in induction of tolerance. J. Immunol. 
151:2390-2398. 
108  Contact Hypersensitivity and Irritant Responses in Ib4T and Ibl0T Mice 